|
Name |
paecilin J
|
| Molecular Formula | C32H30O14 | |
| IUPAC Name* |
methyl5-hydroxy-8-[5-hydroxy-2-methoxycarbonyl-2-(3-methyl-5-oxooxolan-2-yl)-4-oxo-3H-chromen-8-yl]-2-(3-methyl-5-oxooxolan-2-yl)-4-oxo-3H-chromene-2-carboxylate
|
|
| SMILES |
COC(=O)C1(C2OC(=O)CC2C)CC(=O)c2c(O)ccc(-c3ccc(O)c4c3OC(C(=O)OC)(C3OC(=O)CC3C)CC4=O)c2O1
|
|
| InChI |
InChI=1S/C32H30O14/c1-13-9-21(37)43-27(13)31(29(39)41-3)11-19(35)23-17(33)7-5-15(25(23)45-31)16-6-8-18(34)24-20(36)12-32(30(40)42-4,46-26(16)24)28-14(2)10-22(38)44-28/h5-8,13-14,27-28,33-34H,9-12H2,1-4H3/t13-,14-,27+,28+,31-,32-/m0/s1
|
|
| InChIKey |
UJORNCQXCUJGMA-PMHDQPJQSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 638.58 | ALogp: | 2.4 |
| HBD: | 2 | HBA: | 14 |
| Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 198.3 | Aromatic Rings: | 6 |
| Heavy Atoms: | 46 | QED Weighted: | 0.357 |
| Caco-2 Permeability: | -5.153 | MDCK Permeability: | 0.00003000 |
| Pgp-inhibitor: | 0.742 | Pgp-substrate: | 0.004 |
| Human Intestinal Absorption (HIA): | 0.712 | 20% Bioavailability (F20%): | 0.004 |
| 30% Bioavailability (F30%): | 0.756 |
| Blood-Brain-Barrier Penetration (BBB): | 0.025 | Plasma Protein Binding (PPB): | 84.78% |
| Volume Distribution (VD): | 0.344 | Fu: | 7.23% |
| CYP1A2-inhibitor: | 0.044 | CYP1A2-substrate: | 0.737 |
| CYP2C19-inhibitor: | 0.3 | CYP2C19-substrate: | 0.065 |
| CYP2C9-inhibitor: | 0.747 | CYP2C9-substrate: | 0.726 |
| CYP2D6-inhibitor: | 0.067 | CYP2D6-substrate: | 0.179 |
| CYP3A4-inhibitor: | 0.891 | CYP3A4-substrate: | 0.477 |
| Clearance (CL): | 15.865 | Half-life (T1/2): | 0.066 |
| hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.794 |
| Drug-inuced Liver Injury (DILI): | 0.971 | AMES Toxicity: | 0.055 |
| Rat Oral Acute Toxicity: | 0.94 | Maximum Recommended Daily Dose: | 0.1 |
| Skin Sensitization: | 0.016 | Carcinogencity: | 0.148 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
| Respiratory Toxicity: | 0.004 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002448 | ![]() |
1.000 | D01XWG | ![]() |
0.258 | ||
| ENC005733 | ![]() |
0.775 | D01UBX | ![]() |
0.256 | ||
| ENC005732 | ![]() |
0.684 | D0T5XN | ![]() |
0.252 | ||
| ENC003348 | ![]() |
0.641 | D01XDL | ![]() |
0.251 | ||
| ENC005727 | ![]() |
0.610 | D07VLY | ![]() |
0.247 | ||
| ENC005729 | ![]() |
0.600 | D0C9XJ | ![]() |
0.247 | ||
| ENC005885 | ![]() |
0.569 | D07IPB | ![]() |
0.239 | ||
| ENC005734 | ![]() |
0.543 | D0T8EH | ![]() |
0.236 | ||
| ENC005735 | ![]() |
0.533 | D08LTU | ![]() |
0.231 | ||
| ENC005069 | ![]() |
0.528 | D0Q0PR | ![]() |
0.231 | ||